A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Palmoplantar Pustulosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • LEO Pharma Investigational Site, Fountain Valley, California, United States

  • LEO Pharma Investigational Site, Douglasville, Georgia, United States

  • LEO Pharma Investigational Site, West Bloomfield, Michigan, United States

  • LEO Pharma Investigational Site, Elmhurst, New York, United States

  • LEO Pharma Investigation Site, Mayfield Heights, Ohio, United States

  • LEO Pharma Investigational Site, Portland, Oregon, United States

  • LEO Pharma Investigational Site, Philadelphia, Pennsylvania, United States

  • LEO Pharma Investigational Site, Calgary, Alberta, Canada

  • LEO Pharma Investigational Site, Surrey, British Columbia, Canada

  • LEO Pharma Investigational Site, Winnipeg, Manitoba, Canada

  • LEO Pharma Investigational Site, Fredericton, New Brunswick, Canada

  • LEO Pharma Investigational Site, Hamilton, Ontario, Canada

  • LEO Pharma Investigational Site, Hamilton, Ontario, Canada

  • LEO Pharma Investigational Site, Markham, Ontario, Canada

  • LEO Pharma Investigational Site, Waterloo, Ontario, Canada

  • LEO Pharma Investigational Site, Montreal, Quebec, Canada

  • LEO Pharma Investigational Site, Bad Bentheim, Germany

  • LEO Pharma Investigational Site, Dresden, Germany

  • LEO Pharma Investigational Site, Göttingen, Germany

  • LEO Pharma Investigational Site, Kiel, Germany

  • LEO Pharma Investigational Site, Lübeck, Germany

  • LEO Pharma Investigational Site, Manheim, Germany

  • LEO Pharma Investigational Site, Münster, Germany

  • LEO Pharma Investigational Site, Osnabrück, Germany

  • LEO Pharma Investigational Site, Witten, Germany

  • LEO Pharma Investigational Site, Bialystok, Poland

  • LEO Pharma Investigational Site, Iwonicz-Zdrój, Poland

  • LEO Pharma Investigational Site, Lodz, Poland

  • LEO Pharma Investigational Site, Lublin, Poland

  • LEO Pharma Investigational Site, Rzeszów, Poland

  • LEO Pharma Investigational Site, Warsaw, Poland

  • LEO Pharma Investigational Site, Wroclaw, Poland

  • LEO Pharma Investigational Site, Wroclaw, Poland

  • LEO Pharma Investigational Site, Bristol, United Kingdom

  • LEO Pharma Investigational Site, London, United Kingdom

  • LEO Pharma Investigational Site, Newcastle upon Tyne, United Kingdom

  • LEO Pharma Investigational Site, Salford, United Kingdom

  • LEO Pharma Investigational Site, Stourbridge, United Kingdom

מובילי המחקר
  • Medical Expert

    Study Director

    LEO Pharma